Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lymphoma"" wg kryterium: Temat


Starter badań:

Tytuł :
Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma.
Autorzy :
Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .
Kuravi S; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA.
Ganguly S; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA.
Welch DR; The University of Kansas Cancer Center, Kansas City, USA; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, USA.
Vivian CJ; The University of Kansas Cancer Center, Kansas City, USA; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, USA.
Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA.
Hegde A; Department of Hematology/Oncology, University of Alabama, Birmingham, USA.
Iyer S; Department of Myeloma and Lymphoma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
Behrang A; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Ali SM; Foundation Medicine, Cambridge, USA.
Madison RW; Foundation Medicine, Cambridge, USA.
Venstrom JM; Foundation Medicine, Cambridge, USA.
Jensen RA; The University of Kansas Cancer Center, Kansas City, USA; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, USA.
McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA.
Amin HM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Balusu R; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA. Electronic address: .
Pokaż więcej
Źródło :
ESMO open [ESMO Open] 2021 Aug; Vol. 6 (4), pp. 100172. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, Large-Cell, Anaplastic*/genetics
Anaplastic Lymphoma Kinase/genetics ; Humans ; Prospective Studies ; Pyrimidines ; Receptor Protein-Tyrosine Kinases/genetics ; Sulfones
Czasopismo naukowe
Tytuł :
Ongoing excellent outcomes with reduced toxicities following integration of molecular targeted therapies in pediatric anaplastic large cell lymphoma.
Autorzy :
McCarthy P; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.; Systems Biology Ireland, School of Medicine, University College Dublin, Ireland.
Harford J; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
O'Marcaigh A; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
Malone A; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
Evans P; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
Sills A; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
Storey L; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
Rooney S; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
Betts D; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
O'Sullivan MJ; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
McDermott M; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.
Bond J; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.; Systems Biology Ireland, School of Medicine, University College Dublin, Ireland.; National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland.
Trinquand A; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.; National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland.
Smith OP; National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland.; Systems Biology Ireland, School of Medicine, University College Dublin, Ireland.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Aug; Vol. 62 (8), pp. 1995-1999. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji :
Letter
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/diagnosis
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Anaplastic Lymphoma Kinase/genetics ; Brentuximab Vedotin ; Child ; Humans ; Longitudinal Studies ; Molecular Targeted Therapy
Opinia redakcyjna
Tytuł :
MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies.
Autorzy :
Liang X; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Cao Y; School of Pharmacy, Fudan University, Shanghai, China.
Li C; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Yu H; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Yang C; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Liu H; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Pokaż więcej
Źródło :
Medicinal research reviews [Med Res Rev] 2021 Jul; Vol. 41 (4), pp. 2388-2422. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Autoimmune Diseases*
Lymphoma*
Humans ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein ; NF-kappa B ; Neoplasm Proteins/genetics
Czasopismo naukowe
Tytuł :
MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphoma.
Autorzy :
Sinatkas V; Department of Pathology, University of Crete, Medical School, Heraklion, Greece.
Stathopoulou K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Xagoraris I; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Ye J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
Vyrla D; Department of Pathology, University of Crete, Medical School, Heraklion, Greece.
Atsaves V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Leventaki V; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.
Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rassidakis GZ; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Drakos E; Department of Pathology, University of Crete, Medical School, Heraklion, Greece.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Jul; Vol. 62 (7), pp. 1563-1573. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/genetics
Proto-Oncogene Proteins*
Receptor Protein-Tyrosine Kinases*/genetics
Anaplastic Lymphoma Kinase/genetics ; Cell Cycle ; Cell Cycle Proteins/genetics ; Cell Line, Tumor ; Humans
Czasopismo naukowe
Tytuł :
All activated signaling pathways lead to anaplastic large cell lymphoma (ALCL).
Autorzy :
Bonzheim I; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.
Quintanilla-Martinez L; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Jul; Vol. 62 (7), pp. 1541-1543. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*
Anaplastic Lymphoma Kinase ; Humans ; Signal Transduction
Czasopismo naukowe
Tytuł :
Initial Manifestation of Orbital Lymphomas: The Role of Early Diagnosis.
Autorzy :
Torres LHS; Department of Diagnosis and Surgery, São Paulo State University (UNESP), Dental School of Araraquara, São Paulo, Brazil.
Gabrielli MAC
Pererira Filho VA
Pokaż więcej
Źródło :
The Journal of craniofacial surgery [J Craniofac Surg] 2021 Jul-Aug 01; Vol. 32 (5), pp. e468-e470.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Lymphoma, B-Cell, Marginal Zone*
Orbital Neoplasms*/diagnosis
Orbital Neoplasms*/surgery
Adult ; Early Detection of Cancer ; Female ; Humans ; Lymphoma ; Male ; Neoplasm Recurrence, Local
SCR Disease Name :
Orbital lymphoma
Czasopismo naukowe
Tytuł :
[Human immunodeficiency virus and lymphoma].
Autorzy :
Tazi I; CHU Mohamed VI, Université Cadi Ayyad, Faculté de Médecine, Service d'Hématologie Clinique, Marrakech, Maroc. Electronic address: .
Lahlimi FZ; CHU Mohamed VI, Université Cadi Ayyad, Faculté de Médecine, Service d'Hématologie Clinique, Marrakech, Maroc.
Pokaż więcej
Transliterated Title :
Virus de l’immunodéficience humaine et lymphome.
Źródło :
Bulletin du cancer [Bull Cancer] 2021 Oct; Vol. 108 (10), pp. 953-962. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
HIV Infections/*complications
Lymphoma, AIDS-Related/*virology
Anti-HIV Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Burkitt Lymphoma/drug therapy ; Burkitt Lymphoma/pathology ; Burkitt Lymphoma/virology ; Castleman Disease/drug therapy ; Castleman Disease/pathology ; Castleman Disease/virology ; HIV Infections/drug therapy ; HIV Seropositivity/complications ; Hodgkin Disease/drug therapy ; Hodgkin Disease/pathology ; Hodgkin Disease/virology ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunocompromised Host ; Incidence ; Lymphoma, AIDS-Related/drug therapy ; Lymphoma, AIDS-Related/epidemiology ; Lymphoma, AIDS-Related/pathology ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/pathology ; Lymphoma, Large B-Cell, Diffuse/virology ; Lymphoma, Primary Effusion/drug therapy ; Lymphoma, Primary Effusion/pathology ; Lymphoma, Primary Effusion/virology ; Plasmablastic Lymphoma/drug therapy ; Plasmablastic Lymphoma/pathology ; Plasmablastic Lymphoma/virology ; Prognosis ; Recurrence
Czasopismo naukowe
Tytuł :
B Cell Lymphomas of the GI Tract.
Autorzy :
Small S; Division of Hematology/Oncology, Northwestern University, Chicago, IL, USA.
Barnea Slonim L; Division of Pathology, Northwestern University, Chicago, IL, USA.
Williams C; Robert H. Lurie Comprehensive Cancer Center, 675 N. St. Clair St.Fl 21 Ste. 100, Chicago, IL, 60611, USA.
Karmali R; Division of Hematology/Oncology, Northwestern University, Chicago, IL, USA. .; Robert H. Lurie Comprehensive Cancer Center, 675 N. St. Clair St.Fl 21 Ste. 100, Chicago, IL, 60611, USA. .
Pokaż więcej
Źródło :
Current gastroenterology reports [Curr Gastroenterol Rep] 2021 May 08; Vol. 23 (7), pp. 9. Date of Electronic Publication: 2021 May 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gastrointestinal Neoplasms*/genetics
Gastrointestinal Neoplasms*/physiopathology
Gastrointestinal Neoplasms*/therapy
Lymphoma, B-Cell*/diagnosis
Lymphoma, B-Cell*/genetics
Lymphoma, B-Cell*/physiopathology
Lymphoma, B-Cell*/therapy
Humans ; Lymphoma, Follicular/diagnosis ; Lymphoma, Follicular/genetics ; Lymphoma, Follicular/physiopathology ; Lymphoma, Follicular/therapy ; Lymphoproliferative Disorders/diagnosis ; Lymphoproliferative Disorders/etiology ; Lymphoproliferative Disorders/physiopathology ; Lymphoproliferative Disorders/therapy
Czasopismo naukowe
Tytuł :
[Role of radiotherapy in haematology].
Autorzy :
Peignaux-Casasnovas K; Département de radiothérapie, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21079 Dijon, France. Electronic address: .
Truc G; Département de radiothérapie, centre Georges-François-Leclerc, 1, rue du Professeur-Marion, 21079 Dijon, France.
Rossi C; Service d'hématologie, CHU de François-Mitterrand, 21000 Dijon, France.
Casasnovas O; Service d'hématologie, CHU de François-Mitterrand, 21000 Dijon, France.
Pokaż więcej
Transliterated Title :
Place de la radiothérapie en hématologie.
Źródło :
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2021 Oct; Vol. 25 (6-7), pp. 603-606. Date of Electronic Publication: 2021 Aug 28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Leukemia/*radiotherapy
Lymphoma/*radiotherapy
Skin Neoplasms/*radiotherapy
Acute Disease ; Hodgkin Disease/pathology ; Hodgkin Disease/radiotherapy ; Humans ; Leukemia/pathology ; Lymphoma, Non-Hodgkin/pathology ; Lymphoma, Non-Hodgkin/radiotherapy ; Multiple Myeloma/radiotherapy ; Plasmacytoma/radiotherapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/radiotherapy ; Sarcoma/radiotherapy ; Skin Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Disseminated indolent ALK-positive primary cutaneous anaplastic large cell lymphoma (C-ALCL) lasting for 10 years.
Autorzy :
Barbé J; Dermatology Department, University Hospital of Nancy, Vandoeuvre les Nancy, France.
Escobar G; Dermatology Department, University Hospital of Nancy, Vandoeuvre les Nancy, France.
Marzouki-Zerouali A; Dermatology Department, University Hospital of Nancy, Vandoeuvre les Nancy, France.
Lardenois E; Pathologist Department, University Hospital of Nancy, Vandoeuvre les Nancy, France.
Schmutz JL; Dermatology Department, University Hospital of Nancy, Vandoeuvre les Nancy, France.
Bursztejn AC; Dermatology Department, University Hospital of Nancy, Vandoeuvre les Nancy, France.
Pokaż więcej
Źródło :
International journal of dermatology [Int J Dermatol] 2021 Apr; Vol. 60 (4), pp. e146-e147. Date of Electronic Publication: 2020 Nov 29.
Typ publikacji :
Letter
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, Primary Cutaneous Anaplastic Large Cell*/drug therapy
Skin Neoplasms*
Anaplastic Lymphoma Kinase/genetics ; Humans
Opinia redakcyjna
Tytuł :
Leukemic presentation with discordant morphology in triple-hit lymphoma-A diagnostic pitfall during COVID-19 pandemic.
Autorzy :
Ray D; Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Mallik N; Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Sreedharanunni S; Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Jain A; Department of Internal Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Bal A; Department of Histopathology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Sachdeva MUS; Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2021 Dec; Vol. 43 (6), pp. e300-e302. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Biopsy*
COVID-19*
Delayed Diagnosis*
Pandemics*
SARS-CoV-2*
Lymph Nodes/*pathology
Lymphocytes/*pathology
Lymphoma, Large B-Cell, Diffuse/*diagnosis
Adult ; Antigens, CD/analysis ; Antigens, Neoplasm/analysis ; B-Lymphocytes/chemistry ; B-Lymphocytes/pathology ; Biomarkers, Tumor/blood ; Diagnosis, Differential ; Gene Rearrangement, B-Lymphocyte, Heavy Chain ; Humans ; Immunophenotyping ; In Situ Hybridization, Fluorescence ; Leukemia/diagnosis ; Lymphocytes/chemistry ; Lymphoma, Follicular/diagnosis ; Lymphoma, Large B-Cell, Diffuse/blood ; Lymphoma, Large B-Cell, Diffuse/classification ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male
Raport
Tytuł :
The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltrating blood and bone marrow - Results from a single centre pilot study.
Autorzy :
Gautam A; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sreedharanunni S; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sachdeva MUS; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Rana S; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Kashyap D; Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Bose P; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Bal A; Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Prakash G; Adult Clinical Hematology and Bone Marrow Transplantation Unit, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Malhotra P; Adult Clinical Hematology and Bone Marrow Transplantation Unit, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Das R; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Varma N; Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2021 Oct; Vol. 43 (5), pp. 1123-1131. Date of Electronic Publication: 2021 Jan 17.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD/*analysis
B-Lymphocytes/*pathology
Bone Marrow/*pathology
Lymphoma, B-Cell/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Flow Cytometry ; Humans ; Immunophenotyping ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Lymphoma, B-Cell/pathology ; Lymphoma, Mantle-Cell/diagnosis ; Lymphoma, Mantle-Cell/pathology ; Male ; Middle Aged ; Prospective Studies ; Receptor-Like Protein Tyrosine Phosphatases, Class 3/analysis ; Young Adult
Czasopismo naukowe
Tytuł :
Ibrutinib improves the efficacy of anti-CD19-CAR T-cell therapy in patients with refractory non-Hodgkin lymphoma.
Autorzy :
Liu M; The First Central Clinical College of Tianjin Medical University, Tianjin, China.
Deng H; The First Central Clinical College of Tianjin Medical University, Tianjin, China.
Mu J; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Li Q; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Pu Y; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Jiang Y; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Deng Q; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Qian Z; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2021 Jul; Vol. 112 (7), pp. 2642-2651. Date of Electronic Publication: 2021 May 10.
Typ publikacji :
Journal Article
MeSH Terms :
Receptors, Chimeric Antigen*/genetics
Salvage Therapy*
Adenine/*analogs & derivatives
Immunotherapy, Adoptive/*methods
Lymphoma, Follicular/*therapy
Lymphoma, Mantle-Cell/*therapy
Piperidines/*therapeutic use
Adenine/therapeutic use ; Adult ; Aged ; Combined Modality Therapy/methods ; Disease Progression ; Drug Resistance, Neoplasm ; Female ; Humans ; Immunotherapy, Adoptive/adverse effects ; Interleukin-6/blood ; Interleukin-8/blood ; Lymphoma, B-Cell/blood ; Lymphoma, B-Cell/therapy ; Lymphoma, Follicular/blood ; Lymphoma, Large B-Cell, Diffuse/blood ; Lymphoma, Large B-Cell, Diffuse/therapy ; Lymphoma, Mantle-Cell/blood ; Male ; Middle Aged ; Receptors, Interleukin-2/blood ; Remission Induction/methods ; Retreatment ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[Genetic abnormality and protein expression of C-MYC and PD-L1 in ALK-negative anaplastic large cell lymphoma].
Autorzy :
Wang C; Department of Pathology, Fujian Provincial Hospital, Fujian Provincial; Clinical College of Fujian Medical University, Fuzhou 350001, China.
Chen X; Department of Pathology, Fujian Provincial Hospital, Fujian Provincial; Clinical College of Fujian Medical University, Fuzhou 350001, China.
Chen XY; Department of Pathology, Fujian Provincial Hospital, Fujian Provincial; Clinical College of Fujian Medical University, Fuzhou 350001, China.
You ZJ; Department of Pathology, Fujian Provincial Hospital, Fujian Provincial; Clinical College of Fujian Medical University, Fuzhou 350001, China.
Pokaż więcej
Źródło :
Zhonghua bing li xue za zhi = Chinese journal of pathology [Zhonghua Bing Li Xue Za Zhi] 2021 Jun 08; Vol. 50 (6), pp. 598-603.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, Large-Cell, Anaplastic*/genetics
Anaplastic Lymphoma Kinase/genetics ; B7-H1 Antigen/genetics ; Genes, myc ; Humans ; In Situ Hybridization, Fluorescence ; Proto-Oncogene Proteins c-myc ; Receptor Protein-Tyrosine Kinases/genetics
Czasopismo naukowe
Tytuł :
The impact of granulocyte colony stimulating factor on patients receiving chimeric antigen receptor T-cell therapy.
Autorzy :
Barreto JN; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
Bansal R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Hathcock MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Doleski CJ; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
Hayne JR; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Truong TA; Department of Nursing, Mayo Clinic, Rochester, Minnesota, USA.
Nedved AN; Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
Ansell SM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Bennani NN; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Paludo J; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Villasboas JC; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Lin Y; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Johnston PB; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2021 Oct 01; Vol. 96 (10), pp. E399-E402. Date of Electronic Publication: 2021 Aug 14.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural
MeSH Terms :
Antigens, CD19/*therapeutic use
Granulocyte Colony-Stimulating Factor/*therapeutic use
Lymphoma, Large B-Cell, Diffuse/*therapy
Adult ; Female ; Humans ; Immunotherapy, Adoptive ; Lymphoma, Follicular/therapy ; Male ; Middle Aged ; Retrospective Studies
Raport
Tytuł :
Combination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL).
Autorzy :
Chen MT; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Fu XH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.; Department of Medical Oncology, Shenzhen Nanshan People's Hospital, Shenzhen, China.; Department of Medical Oncology, Affiliated Shenzhen Sixth Hospital of Guangdong Medical University, Shenzhen, China.
Huang H; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Wang Z; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Fang XJ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Yao YY; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Ren QG; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Chen ZG; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Lin TY; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Mar; Vol. 62 (3), pp. 571-580. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lung Neoplasms*
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, T-Cell, Peripheral*
Anaplastic Lymphoma Kinase/genetics ; Crizotinib/therapeutic use ; Humans ; Progression-Free Survival ; Protein Kinase Inhibitors/adverse effects
Czasopismo naukowe
Tytuł :
Mantle cell lymphoma with EBV-positive Hodgkin and Reed-Sternberg-like cells in a patient after autologous PBSCT: Phenotypically distinct but genetically related tumors.
Autorzy :
Kanai R; Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Miyagawa-Hayashino A; Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Shishido-Hara Y; Department of Pathology and Applied Neurobiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Nakamura N; Department of Pathology, Tokai University School of Medicine, Kyoto, Japan.
Omatsu I; Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Morinaga Y; Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Shimura Y; Department of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kuroda J; Department of Medicine, Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Imura T; Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Itoh K; Department of Pathology and Applied Neurobiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Konishi E; Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło :
Pathology international [Pathol Int] 2021 Jan; Vol. 71 (1), pp. 96-101. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Case Reports
MeSH Terms :
Lymphoma, Mantle-Cell*/diagnosis
Lymphoma, Mantle-Cell*/pathology
Aged ; Autografts/abnormalities ; Biomarkers, Tumor/analysis ; Cyclin D1/analysis ; Epstein-Barr Virus Infections/complications ; Herpesvirus 4, Human/isolation & purification ; Hodgkin Disease/pathology ; Humans ; In Situ Hybridization, Fluorescence ; Lymph Nodes/pathology ; Lymphoma, B-Cell/diagnosis ; Lymphoma, B-Cell/pathology ; Male ; Reed-Sternberg Cells/cytology ; Tumor Suppressor Protein p53/analysis
Raport
Tytuł :
Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
Autorzy :
Zic JA; Department of Dermatology, VU Cutaneous Lymphoma Clinic, Vanderbilt University Medical Center, Vanderbilt Dermatology, One Hundred Oaks, 719 Thompson Lane, Suite 26300, Nashville, TN 37204-3609, USA. Electronic address: .
Pokaż więcej
Źródło :
The Medical clinics of North America [Med Clin North Am] 2021 Jul; Vol. 105 (4), pp. 737-755.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Lymphoma, T-Cell, Cutaneous/*diagnosis
Lymphoma, T-Cell, Cutaneous/*therapy
Skin Diseases/*diagnosis
Skin Neoplasms/*pathology
Aged ; Aged, 80 and over ; Animals ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Arthropods ; Bexarotene/adverse effects ; Bites and Stings/diagnosis ; Brentuximab Vedotin/adverse effects ; Diagnosis, Differential ; Humans ; Hyperlipidemias/chemically induced ; Hypothyroidism/chemically induced ; Lymphoma, Primary Cutaneous Anaplastic Large Cell/diagnosis ; Lymphoma, T-Cell, Cutaneous/classification ; Lymphomatoid Papulosis/diagnosis ; Mycosis Fungoides/diagnosis ; Peripheral Nervous System Diseases/chemically induced ; Prognosis ; Sezary Syndrome/diagnosis ; Skin Diseases/pathology
Czasopismo naukowe
Tytuł :
Treatment selection and survival outcomes in Early-Stage peripheral T-Cell lymphomas: does anaplastic lymphoma kinase mutation impact the benefit of consolidative radiotherapy?
Autorzy :
Rodríguez-López JL; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Patel AK; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Balasubramani GK; Department of Epidemiology, Epidemiology Data Center, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.
Glaser SM; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, USA.
Beriwal S; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Vargo JA; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Mar; Vol. 62 (3), pp. 538-548. Date of Electronic Publication: 2020 Nov 30.
Typ publikacji :
Journal Article
MeSH Terms :
Lymphoma, T-Cell, Peripheral*/diagnosis
Lymphoma, T-Cell, Peripheral*/genetics
Lymphoma, T-Cell, Peripheral*/therapy
Anaplastic Lymphoma Kinase/genetics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Humans ; Mutation ; Prognosis
Czasopismo naukowe
Tytuł :
"RT or not RT?" The question for early-stage peripheral T-cell lymphoma.
Autorzy :
Campbell BA; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Clinical Pathology, University of Melbourne, Parkville, Australia.
Khot A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 Mar; Vol. 62 (3), pp. 511-513. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Lymphoma, Extranodal NK-T-Cell*/drug therapy
Lymphoma, T-Cell, Peripheral*/diagnosis
Anaplastic Lymphoma Kinase ; Chemoradiotherapy ; Humans ; Mutation
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies